Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Management of Enterococcus Bacteremia

Initial Management

  • The European Society of Cardiology recommends intravenous antibiotics as the standard of care for initial treatment of enterococcal bacteremia, with ampicillin as the drug of choice for ampicillin-susceptible enterococci and vancomycin for ampicillin-resistant enterococci 1, 3
  • Source control, including removal of infected catheters or drainage of abscesses, is critical for the management of enterococcal bacteremia 4, 2
  • Enterococcal bacteremia requires prolonged administration (up to 6 weeks) of synergistic bactericidal combinations for eradication in complicated cases 1

Contraindications to Oral Therapy

  • The European Heart Journal recommends that oral therapy is contraindicated in scenarios such as endocarditis or suspected endocarditis, persistent bacteremia, metastatic infections, and immunocompromised patients 1, 2, 3

Appropriate Oral Antibiotic Options

  • For ampicillin-susceptible enterococci, amoxicillin 500 mg orally every 8 hours is an appropriate oral option, according to the Clinical Infectious Diseases guidelines 2, 6
  • Treatment duration of 7-14 days is recommended for uncomplicated enterococcal bacteremia when source control is achieved, as suggested by the Clinical Infectious Diseases guidelines 3, 2

Monitoring During Oral Therapy

  • Follow-up blood cultures should be obtained to document clearance of bacteremia, and patients should be monitored for clinical response within 48-72 hours of initiating oral therapy, as recommended by the Clinical Infectious Diseases guidelines 2, 5, 6